Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases

IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases

US Patent 9770454 · Granted Sep 26, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations of IRS/STAT3 dual modulators and anti-cancer agents for treating ca2025
Carbazole derivatives for the treatment of fibrotic diseases and related symptom2024
Chimeric proteins for targeting dsRNA2024
Castration resistant prostate cancer2023
Chimeric proteins for targeting dsRNA2022
Carbazole derivatives for the treatment of fibrotic diseases and related symptom2021
Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating ca2021
Carbazole derivatives for the treatment of fibrotic diseases and related symptom2020
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019